Colin Walsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Colin Walsh has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- U. O'Connor
Department of Medical Physics and Bioengineering, St James's Hospital, Dublin, Ireland
3 shared publications - Bradley F. Boeve
Mayo Clinic Rochester
2 shared publications - Chris Berka
Advanced Brain Monitoring, Carlsbad, California
2 shared publications - Daniel J. Levendowski
Advanced Brain Monitoring, Carlsbad, California
2 shared publications - David H. Salat
Neuroimaging Research for Veterans Center, VA Boston Healthcare System, Jamaica Plain, MA USA
2 shared publications - David Shprecher
Banner Sun Health Research Institute, Sun City, United States
2 shared publications
Latest Publications
- 8 October 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (4) , 044002
A criticism of three arguments on recurrent imaging and risk
Managing radiation protection (RP) in relation to recurrent imaging continues to be debated. Recent arguments have focussed on high cumulative effective dose (CED), especially where it exceeds 100 mSv. This article argues that CED should not be the primary focus for tracking concerns on recurrent imaging. Arguments which advocate for increased RP measures after 100 mSv is exceeded are criticised as being in conflict with the linear no threshold model. Finally, a view of dose history as adding to background risk is discussed.
- 8 October 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (4) , 044002
A criticism of three arguments on recurrent imaging and risk
Managing radiation protection (RP) in relation to recurrent imaging continues to be debated. Recent arguments have focussed on high cumulative effective dose (CED), especially where it exceeds 100 mSv. This article argues that CED should not be the primary focus for tracking concerns on recurrent imaging. Arguments which advocate for increased RP measures after 100 mSv is exceeded are criticised as being in conflict with the linear no threshold model. Finally, a view of dose history as adding to background risk is discussed.
- Open Access
- 5 October 2022
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 42 (4) , 041501
Feasibility study of computational occupational dosimetry: evaluating a proof-of-concept in an endovascular and interventional cardiology setting
Individual monitoring of radiation workers is essential to ensure compliance with legal dose limits and to ensure that doses are As Low As Reasonably Achievable. However, large uncertainties still exist in personal dosimetry and there are issues with compliance and incorrect wearing of dosimeters. The objective of the PODIUM (Personal Online Dosimetry Using Computational Methods) project was to improve personal dosimetry by an innovative approach: the development of an online dosimetry application based on computer simulations without the use of physical dosimeters. Occupational doses were calculated based on the use of camera tracking devices, flexible individualised phantoms and data from the radiation source. When combined with fast Monte Carlo simulation codes, the aim was to perform personal dosimetry in real-time. A key component of the PODIUM project was to assess and validate the methodology in interventional radiology workplaces where improvements in dosimetry are needed. This paper describes the feasibility of implementing the PODIUM approach in a clinical setting. Validation was carried out using dosimeters worn by Vascular Surgeons and Interventional Cardiologists during patient procedures at a hospital in Ireland. Our preliminary results from this feasibility study show acceptable differences of the order of 40% between calculated and measured staff doses, in terms of the personal dose equivalent quantity Hp(10), however there is a greater deviation for more complex cases and improvements are needed. The challenges of using the system in busy interventional rooms have informed the future needs and applicability of PODIUM. The availability of an online personal dosimetry application has the potential to overcome problems that arise from the use of current dosimeters. In addition, it should increase awareness of radiation protection among staff. Some limitations remain and a second phase of development would be required to bring the PODIUM method into operation in a hospital setting. However, an early prototype system has been tested in a clinical setting and the results from this two-year proof-of-concept PODIUM project are very promising for future development.
- 5 October 2022
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 42 (4) , 041501
Open AccessFeasibility study of computational occupational dosimetry: evaluating a proof-of-concept in an endovascular and interventional cardiology setting
Individual monitoring of radiation workers is essential to ensure compliance with legal dose limits and to ensure that doses are As Low As Reasonably Achievable. However, large uncertainties still exist in personal dosimetry and there are issues with compliance and incorrect wearing of dosimeters. The objective of the PODIUM (Personal Online Dosimetry Using Computational Methods) project was to improve personal dosimetry by an innovative approach: the development of an online dosimetry application based on computer simulations without the use of physical dosimeters. Occupational doses were calculated based on the use of camera tracking devices, flexible individualised phantoms and data from the radiation source. When combined with fast Monte Carlo simulation codes, the aim was to perform personal dosimetry in real-time. A key component of the PODIUM project was to assess and validate the methodology in interventional radiology workplaces where improvements in dosimetry are needed. This paper describes the feasibility of implementing the PODIUM approach in a clinical setting. Validation was carried out using dosimeters worn by Vascular Surgeons and Interventional Cardiologists during patient procedures at a hospital in Ireland. Our preliminary results from this feasibility study show acceptable differences of the order of 40% between calculated and measured staff doses, in terms of the personal dose equivalent quantity Hp(10), however there is a greater deviation for more complex cases and improvements are needed. The challenges of using the system in busy interventional rooms have informed the future needs and applicability of PODIUM. The availability of an online personal dosimetry application has the potential to overcome problems that arise from the use of current dosimeters. In addition, it should increase awareness of radiation protection among staff. Some limitations remain and a second phase of development would be required to bring the PODIUM method into operation in a hospital setting. However, an early prototype system has been tested in a clinical setting and the results from this two-year proof-of-concept PODIUM project are very promising for future development.
- 1 September 2022
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 42 (3) , 031511
Personal dosimetry for positron emitters, and occupational exposures from clinical use of gallium-68
The current status and issues regarding positron dosimetry in nuclear medicine are summarized. The suitability of the United Kingdom Health Security Agency extremity and eye beta-gamma personal thermoluminescence dosemeters are then considered. Monte Carlo modelling is performed to determine their responses and derive sets of calibration factors, along with H p(0.07) and H p(3) conversion coefficients, for carbon-11, nitrogen-13, oxygen-15, fluorine-18 and gallium-68 sources, which are commonly used in positron emission tomography (PET) computed tomography; data for these isotopes is assumed extrapolatable to other positron sources. It is found that the dosemeters are adequate for assessing exposures to PET radionuclides, even if their routine calibrations to caesium-137 were maintained. An idealized set of measurements representing gallium-68 exposure scenarios is then described, including reproducible mock-ups of individuals manipulating vials and syringes. Finally, a short case-study is presented that explores occupational doses during routine clinical use of gallium-68. The extremity dosemeter results demonstrated significant variations dependent upon the exposure conditions, with some seen to be comparatively large; whole-body and eye dose rates per activity were found to be lower. The importance of routine dose monitoring of workers is emphasized, with the need for a longer-termed follow-up study demonstrated.
- 1 September 2022
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 42 (3) , 031511
Personal dosimetry for positron emitters, and occupational exposures from clinical use of gallium-68
The current status and issues regarding positron dosimetry in nuclear medicine are summarized. The suitability of the United Kingdom Health Security Agency extremity and eye beta-gamma personal thermoluminescence dosemeters are then considered. Monte Carlo modelling is performed to determine their responses and derive sets of calibration factors, along with H p(0.07) and H p(3) conversion coefficients, for carbon-11, nitrogen-13, oxygen-15, fluorine-18 and gallium-68 sources, which are commonly used in positron emission tomography (PET) computed tomography; data for these isotopes is assumed extrapolatable to other positron sources. It is found that the dosemeters are adequate for assessing exposures to PET radionuclides, even if their routine calibrations to caesium-137 were maintained. An idealized set of measurements representing gallium-68 exposure scenarios is then described, including reproducible mock-ups of individuals manipulating vials and syringes. Finally, a short case-study is presented that explores occupational doses during routine clinical use of gallium-68. The extremity dosemeter results demonstrated significant variations dependent upon the exposure conditions, with some seen to be comparatively large; whole-body and eye dose rates per activity were found to be lower. The importance of routine dose monitoring of workers is emphasized, with the need for a longer-termed follow-up study demonstrated.
- Open Access
- 20 July 2022
- Published by Elsevier in Sleep Medicine
- Vol. 100, S172
Non-REM sleep Hypertonia in Parkinsonian-Spectrum Disorders
- 20 July 2022
- Published by Elsevier in Sleep Medicine
- Vol. 100, S172
Open AccessNon-REM sleep Hypertonia in Parkinsonian-Spectrum Disorders
- Open Access
- 20 July 2022
- Published by Elsevier in Sleep Medicine
- Vol. 100, S170-S171
Characterization of Neurodegenerative Disorder Subtypes Based on Non-REM Hypertonia and Sleep Spindle Duration
- 20 July 2022
- Published by Elsevier in Sleep Medicine
- Vol. 100, S170-S171
Open AccessCharacterization of Neurodegenerative Disorder Subtypes Based on Non-REM Hypertonia and Sleep Spindle Duration
- 27 May 2020
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 40 (2) , 646-653
Interpretation of risk for low dose radiation exposures: inconsistencies, philosophical problems and fallacies
Low doses of radiation are used in diagnostic tests such as X-rays or CT exams. A Linear No Threshold model (LNT) is used to assess radiation risk. According to this model, risk decreases linearly with a decreasing dose, with no lower threshold. However, there is no definitive evidence to support risk at very low doses and the model relies on extrapolation to estimate risk at doses below a few 10 s mSv. The simplicity of the LNT model can disguise the more complex questions that arise when the facts are uncertain. There is a considerable debate over how best to interpret and communicate these risks for low dose exposures. This paper criticises arguments on both sides of this debate. In discussing the case for asserting risk we argue that it is only as a scientific model that LNT should be used to make predictions that can be tested. Taking the further step of using these calculations to state how many cancers are caused by the use of X-rays requires a strong scientific model and the disputed status of the LNT model and the consequent uncertainty as to whether low dose radiation definitely causes cancer, is the major obstacle to making these types of claims. In discussing arguments which tend to dismiss risk, we identify the hidden premises needed to support these claims. Differences between a prudent model and a scientific model are considered. A ‘reductio ad absurdum’ objection, and fallacies of ambiguity, where ‘insignificant risk’ may be confused with ‘inconsequential risk’, are also discussed. Disagreement over the interpretation of risk has the potential to disrupt the optimum use of medical imaging technology. While communication of risk need not address the underlying philosophical complexities, advice from the radiation protection community must be rooted in an awareness of these issues if inconsistencies are to be avoided.
- 27 May 2020
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 40 (2) , 646-653
Interpretation of risk for low dose radiation exposures: inconsistencies, philosophical problems and fallacies
Low doses of radiation are used in diagnostic tests such as X-rays or CT exams. A Linear No Threshold model (LNT) is used to assess radiation risk. According to this model, risk decreases linearly with a decreasing dose, with no lower threshold. However, there is no definitive evidence to support risk at very low doses and the model relies on extrapolation to estimate risk at doses below a few 10 s mSv. The simplicity of the LNT model can disguise the more complex questions that arise when the facts are uncertain. There is a considerable debate over how best to interpret and communicate these risks for low dose exposures. This paper criticises arguments on both sides of this debate. In discussing the case for asserting risk we argue that it is only as a scientific model that LNT should be used to make predictions that can be tested. Taking the further step of using these calculations to state how many cancers are caused by the use of X-rays requires a strong scientific model and the disputed status of the LNT model and the consequent uncertainty as to whether low dose radiation definitely causes cancer, is the major obstacle to making these types of claims. In discussing arguments which tend to dismiss risk, we identify the hidden premises needed to support these claims. Differences between a prudent model and a scientific model are considered. A ‘reductio ad absurdum’ objection, and fallacies of ambiguity, where ‘insignificant risk’ may be confused with ‘inconsequential risk’, are also discussed. Disagreement over the interpretation of risk has the potential to disrupt the optimum use of medical imaging technology. While communication of risk need not address the underlying philosophical complexities, advice from the radiation protection community must be rooted in an awareness of these issues if inconsistencies are to be avoided.
- 1 May 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1049) , 20140627
Occupational radiation dose to eyes from interventional radiology procedures in light of the new eye lens dose limit from the International Commission on Radiological Protection
In 2011, the International Commission on Radiological Protection (ICRP) recommended a substantial reduction in the equivalent dose limit for the lens of the eye, in line with a reduced threshold of absorbed dose for radiation-induced cataracts. This is of particular relevance in interventional radiology (IR) where it is well established that staff doses can be significant, however, there is a lack of data on IR eye doses in terms of Hp(3). Hp(3) is the personal dose equivalent at a depth of 3 mm in soft tissue and is used for measuring lens dose. We aimed to obtain a reliable estimate of eye dose to IR operators. Lens doses were measured for four interventional radiologists over a 3-month period using dosemeters specifically designed to measure Hp(3). Based on their typical workloads, two of the four interventional radiologists would exceed the new ICRP dose limit with annual estimated doses of 31 and 45 mSv to their left eye. These results are for an "unprotected" eye, and for IR staff who routinely wear lead glasses, the dose beneath the glasses is likely to be significantly lower. Staff eye dose normalized to patient kerma-area product and eye dose per procedure have been included in the analysis. Eye doses to IR operators have been established using a dedicated Hp(3) dosemeter. Estimated annual doses have the potential to exceed the new ICRP limit. We have estimated lens dose to interventional radiologists in terms of Hp(3) for the first time in an Irish hospital setting.
- 1 May 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1049) , 20140627
Occupational radiation dose to eyes from interventional radiology procedures in light of the new eye lens dose limit from the International Commission on Radiological Protection
In 2011, the International Commission on Radiological Protection (ICRP) recommended a substantial reduction in the equivalent dose limit for the lens of the eye, in line with a reduced threshold of absorbed dose for radiation-induced cataracts. This is of particular relevance in interventional radiology (IR) where it is well established that staff doses can be significant, however, there is a lack of data on IR eye doses in terms of Hp(3). Hp(3) is the personal dose equivalent at a depth of 3 mm in soft tissue and is used for measuring lens dose. We aimed to obtain a reliable estimate of eye dose to IR operators. Lens doses were measured for four interventional radiologists over a 3-month period using dosemeters specifically designed to measure Hp(3). Based on their typical workloads, two of the four interventional radiologists would exceed the new ICRP dose limit with annual estimated doses of 31 and 45 mSv to their left eye. These results are for an "unprotected" eye, and for IR staff who routinely wear lead glasses, the dose beneath the glasses is likely to be significantly lower. Staff eye dose normalized to patient kerma-area product and eye dose per procedure have been included in the analysis. Eye doses to IR operators have been established using a dedicated Hp(3) dosemeter. Estimated annual doses have the potential to exceed the new ICRP limit. We have estimated lens dose to interventional radiologists in terms of Hp(3) for the first time in an Irish hospital setting.
- 1 October 2014
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 87 (1042) , 20140373
Eye dose monitoring of PET/CT workers
The objective of the study was to measure eye dose [Hp(3)] to workers in a busy positron emission tomography (PET)/CT centre. Doses were compared with the proposed new annual dose limit of 20 mSv. We used a newly designed dosemeter to measure eye dose [Hp(3)]. Eye dosemeters were worn with an adjustable headband, with the dosemeter positioned adjacent to the left eye. The whole-body dose was also recorded using electronic personal dosemeter (EPD® Mk2; Thermo Electron Corporation, Waltham, MA). Exposed staff included radiographers, nurses and healthcare assistants. The radiographers received the highest exposure of the staff groups studied, with one radiographer receiving an exposure of 0.5 mSv over the 3-month survey period. The estimated maximum eye dose for 1 year is approximately 2 mSv. The numeric value for eye dose was compared with the numeric value for personal dose equivalent to see if one could be used as an indicator for the other. From our data, a conservative estimate of eye dose Hp(3) (mSv) can be made as being up to approximately twice the numeric value for whole-body dose [Hp(10)] (mSv). Eye dose was found to be well within the new proposed annual limit at our PET/CT centre. Routine whole-body dose measurements may be a useful starting point for assessing whether eye dose monitoring should be prioritized in a PET facility. Following the proposal of a reduced eye dose limit, this article provides new measurement data on staff eye doses for PET/CT workers.
- 1 October 2014
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 87 (1042) , 20140373
Eye dose monitoring of PET/CT workers
The objective of the study was to measure eye dose [Hp(3)] to workers in a busy positron emission tomography (PET)/CT centre. Doses were compared with the proposed new annual dose limit of 20 mSv. We used a newly designed dosemeter to measure eye dose [Hp(3)]. Eye dosemeters were worn with an adjustable headband, with the dosemeter positioned adjacent to the left eye. The whole-body dose was also recorded using electronic personal dosemeter (EPD® Mk2; Thermo Electron Corporation, Waltham, MA). Exposed staff included radiographers, nurses and healthcare assistants. The radiographers received the highest exposure of the staff groups studied, with one radiographer receiving an exposure of 0.5 mSv over the 3-month survey period. The estimated maximum eye dose for 1 year is approximately 2 mSv. The numeric value for eye dose was compared with the numeric value for personal dose equivalent to see if one could be used as an indicator for the other. From our data, a conservative estimate of eye dose Hp(3) (mSv) can be made as being up to approximately twice the numeric value for whole-body dose [Hp(10)] (mSv). Eye dose was found to be well within the new proposed annual limit at our PET/CT centre. Routine whole-body dose measurements may be a useful starting point for assessing whether eye dose monitoring should be prioritized in a PET facility. Following the proposal of a reduced eye dose limit, this article provides new measurement data on staff eye doses for PET/CT workers.
- 22 March 2014
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 87 (1037) , 20130682
Should the justification of medical exposures take account of radiation risks from previous examinations?
With the growing availability of dose histories for patients, the question of whether previous diagnostic radiation exposures should affect decisions on future examinations is coming into sharper focus. This article discusses ways in which cumulative dose information may affect our thinking in justifying exposures. Based on a common tendency to see a connection between past and future events even where we know them to be independent—the gambler's fallacy—we may find ourselves treating past risks as if they contribute to the present risk. We take the example of two patients scheduled for CT scans, one with no previous diagnostic radiation exposures, the other with a history of previous CT scans, to show that the risks, and justification process, are equivalent in both cases. For the patient with a history of diagnostic exposures, there are only two possibilities: either harm has been caused or there has been no effect. If previous CT examinations have not caused harm, then, as past risks, they are irrelevant. The patient is in precisely the same position with regard to risk as a patient with no dose history. If harm has been caused, avoiding further diagnostic exposures does not change this outcome; again in this case, a justified radiation examination should proceed. We argue that bringing dose history into the decision process for justifying examinations is contrary to our understanding of risk for low-dose radiation and, rather than improving patient safety, would unnecessarily restrict access to radiation-based diagnostic examinations.
- 22 March 2014
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 87 (1037) , 20130682
Should the justification of medical exposures take account of radiation risks from previous examinations?
With the growing availability of dose histories for patients, the question of whether previous diagnostic radiation exposures should affect decisions on future examinations is coming into sharper focus. This article discusses ways in which cumulative dose information may affect our thinking in justifying exposures. Based on a common tendency to see a connection between past and future events even where we know them to be independent—the gambler's fallacy—we may find ourselves treating past risks as if they contribute to the present risk. We take the example of two patients scheduled for CT scans, one with no previous diagnostic radiation exposures, the other with a history of previous CT scans, to show that the risks, and justification process, are equivalent in both cases. For the patient with a history of diagnostic exposures, there are only two possibilities: either harm has been caused or there has been no effect. If previous CT examinations have not caused harm, then, as past risks, they are irrelevant. The patient is in precisely the same position with regard to risk as a patient with no dose history. If harm has been caused, avoiding further diagnostic exposures does not change this outcome; again in this case, a justified radiation examination should proceed. We argue that bringing dose history into the decision process for justifying examinations is contrary to our understanding of risk for low-dose radiation and, rather than improving patient safety, would unnecessarily restrict access to radiation-based diagnostic examinations.